Accurate prediction of protein-ligand binding affinity is a cornerstone of computer-aided drug discovery, yet the performance of classical scoring functions has remained stagnant.
Accurate prediction of drug-target binding affinity is a critical yet challenging task in computational drug discovery, traditionally hampered by limited labeled data and poor generalization.
This article provides a comprehensive analysis of the physical interactions governing protein-ligand binding, a cornerstone of modern drug discovery.
Accurate prediction of drug-target binding affinity is crucial for computational drug discovery, yet the generalization capability of many deep learning models has been severely overestimated due to pervasive data bias.
Scoring functions are a critical, yet challenging, component of structure-based virtual screening (SBVS), directly impacting the success of modern drug discovery.
This article provides a comprehensive overview of the foundations of Structure-Based Drug Design (SBDD), a pivotal computational approach in modern drug discovery.
This article provides a comprehensive exploration of Graph Neural Networks (GNNs) and their transformative role in predicting protein-ligand interactions, a critical task in modern drug discovery.
This article explores the transformative role of attention mechanisms in computational models for predicting drug-target binding affinity (DTA), a critical task in modern drug discovery.
Accurate prediction of drug-target binding affinity is a cornerstone of modern computational drug discovery, enabling the rapid identification and optimization of therapeutic candidates.
The prediction of protein-ligand binding affinity (PLA) is a cornerstone of modern drug discovery, crucial for identifying and optimizing potential therapeutic compounds.